Evidence registry
Published drug–disease evidence records.
Each record includes graded evidence, PubMed and ClinicalTrials.gov citations, confidence scores, and human-reviewed AI summaries.
AMPK activation suppresses mTOR-mediated proliferation in breast epithelial cells.
PDE5 inhibition elevates pulmonary cGMP, reducing pulmonary vascular resistance.
Cereblon-dependent degradation of IKZF1/3 disrupts myeloma cell survival signaling.
Glucocorticoid-mediated suppression of cytokine storm in severe COVID-19.
mTOR inhibition reduces hamartoma growth in TSC1/TSC2-deficient cells.
Exogenous T4 restores normal thyroid hormone levels and metabolic homeostasis.
Irreversible COX-1 inhibition reduces thromboxane A2-mediated platelet aggregation.
DHT reduction decreases prostate volume and improves urinary flow.
Topical minoxidil prolongs anagen phase; VEGF upregulation may promote follicular perfusion.
Proposed antiviral and immunomodulatory effects via lysosomal pH and autophagy.